4.0 Article

A COL4A4-G394S Variant and Impaired Collagen IV Trimerization in a Patient with Mild Alport Syndrome

Journal

KIDNEY360
Volume 3, Issue 11, Pages 1899-1908

Publisher

AMER SOC NEPHROLOGY
DOI: 10.34067/KID.0005472022

Keywords

glomerular and tubulointerstitial diseases; Alport syndrome; basic science; collagen; genetics

Funding

  1. Japan Society for the Promotion of Science (JSPS) Program for Postdoctoral Fellowships for Research Abroad
  2. Cell Science Research Foundation Program for Fellowships for Early Career Researcher
  3. NIH [R01DK078314, R01DK128660]

Ask authors/readers for more resources

The study utilized cell-based assays to confirm the disruptive effect of the COL4A4-G394S variant on the assembly of collagen IV heterotrimers, leading to an atypical mild form of autosomal recessive Alport syndrome.
Background Missense variants in COL4A genes are often found in patients with an Alport syndrome-like presentation, but their pathogenicity is not always clear. We encountered a woman with microscopic hematuria and proteinuria at 33 years of age with a diagnosis of thin basement membrane disease who was approaching end stage kidney disease at 59 years of age. We hypothesized that this patient's kidney disease was within the spectrum of Alport syndrome. Methods We used histologic, genetic, and biochemical approaches to investigate the mechanisms of kidney disease. By immunofluorescence, we investigated collagen IV chain composition of the glomerular basement membrane (GBM). We employed targeted sequencing to search for pathogenic variants in COL4A and other relevant genes. We utilized N-and C-terminal split NanoLuciferase assays to determine the effect of a novel COL4A4 variant of uncertain significance (VUS) on collagen IV heterotrimer formation in vitro. We transfected COL4A4 expression constructs with split NanoLuciferase fragment-fused COL4A3 and COL4A5 constructs into human embryonic kidney 293T cells. To assay for a3a4a5(IV) heterotrimer formation and secretion, we measured luminescence in cell lysates and culture supernatants from transfected cells. Results Immunostaining suggested that the collagen a3a4a5(IV) network was present throughout the patient's GBMs. DNA sequencing revealed a novel homozygous VUS: COL4A4 c.1180G.A (p. Gly394Ser). In the C-terminal split luciferase-based a3a4a5(IV) heterotrimer formation assays, luminescence levels for G394S were comparable to WT, but in the N-terminal tag assays, the extracellular luminescence levels for G394S were decreased by approximately 50% compared with WT. Conclusions Our cell-based assay provides a platform to test COL4 VUS and shows that G394S impairs assembly of the a3a4a5(IV) N-terminus and subsequent trimer secretion. These data suggest that the COL4A4-G394S variant is pathogenic and causes an atypical mild form of autosomal recessive Alport syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available